Professional Practice policy-67: injectable opioid agonist treatment
Professional Practice Policy-67 sets out requirements for pharmacist-supervised injectable hydromorphone maintenance treatment within community pharmacies.
This policy aligns with “Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder" developed by the BC Centre on Substance Use. The Guidance document expands the continuum of care for opioid use disorder. It provides treatment options for individuals who have not benefitted from opioid agonist treatment, which includes the oral medications, buprenorphine/naloxone, methadone and slow release oral morphine.
Professional Practice Policy-67: Injectable Opioid Agonist Treatment and the accompanying Policy Guide for Injectable Hydromorphone Maintenance Treatment complement the College’s existing opioid agonist treatment requirements.
Professional Practice Policy-67 and the accompanying Policy Guide for Injectable Hydromorphone Maintenance Treatment were approved for implementation by the College Board at its June 2018 meeting and will be in effect as of September 1, 2018.
|Opioid Agonist Treatment Guides|
Declaration of Completion
Learn how to submit a declaration of successful completion of these requirement through eServices at:
- ReadLinks: New Policy on Injectable Opioid Agonist Treatment (iOAT) Coming Soon (CPBC)
- Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder (BCCSU)
- Opioid Agonist Treatment (CPBC)
- PPP-66 Opioid Agonist Treatment
- PPP-66 Policy Guide: Buprenorphine/Naloxone Maintenance Treatment (2018)
- PPP-66 Policy Guide: Methadone Maintenance Treatment (2013)
- PPP-66 Policy Guide: Slow Release Oral Morphine Maintenance (SROM) Treatment (2018)
- A Guideline for the Clinical Management of Opioid Use Disorder (BCCSU)
- Webinar: Provincial Guidelines for the Clinical Management of Opioid Use Disorder (BCCSU)
- Certification of Practicing Pharmacists for Drug Administration
- Certification in Cardiopulmonary Resuscitation and First Aid
- University of British Columbia Faculty of Medicine, Continuing Professional Development’s, Provincial Opioid Addiction Treatment Support Program
- NAPRA Model Standards for Pharmacy Compounding of Non-hazardous Sterile Preparations
- BC Center for Substance Use Education and Training
- Did you know? Buprenorphine/Naloxone (BCCSU)
- Did you know? Slow-release oral morphine (BCCSU)
- Frequently Asked Questions Buprenorphine/Naloxone Treatment (BCCSU)
- BC Center For Substance Use ReadLinks Series
- How to use Naloxone to Save a Life
- Expanding Access to Injectable Opioid Agonist Treatment - Pharmacist Perspective on Narcotics Handling, Hydromorphone, and iOAT